Back to search results

Educating Denver Health Patients on HPV Vaccine Uptake

This study aims to improve the number of people who get and complete the Human Papilloma Virus (HPV) vaccine. Researchers are testing an "HPV Educational Intervention" which includes videos and materials from the National Cancer Institute (NCI). This intervention will be given to Denver Health patients aged 18-26 who haven't finished their HPV vaccine series, or to parents of Denver Health patients aged 9-17 whose children haven't finished the series. The study will measure if this education increases parents' and young adults' knowledge and their plans to get the HPV vaccine. They will also look at how factors like age and income relate to vaccine uptake. This study is currently unclear on its recruitment status and plans to enroll 1000 participants.

Study design
This study is an interventional study with a planned enrollment of 1000 participants. It uses a one-group post-test design to assess the effects of the educational intervention.
What's involved
You would receive an educational intervention, which includes videos and toolkit materials. A survey will be administered at the beginning of the study.
Compensation
Not stated in the trial record.
Follow-up
The study will track participants who receive HPV vaccine doses and referrals to care. Clinic-level HPV vaccine rates will be tracked quarterly after the intervention is introduced.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04611022

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

Recruiting
NAAges 18+InterventionalPrevention
University of Colorado, Denver
~1,000 participants
Updated 2025-11-25 on ClinicalTrials.gov
What's tested:HPV Educational Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The change in parents & young adults' knowledge & intentions to obtain the HPV vaccine
Measured over Day 0/Baseline
+1 more outcome measured

Conditions

Human Papilloma Virus

Explore related trials

Human Papillomavirus Infection

Where it's being run

1 sites across 1 states
Colorado1

Study leadership

  • Evelinn Borrayo · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Sindy Gonzalez
[email protected]
303-724-5445
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Denver Health patients will be identified from one of the following clinics; Denver Health Clinics Eastside Adult Clinic, Eastside Women's Care Clinic, Westside Adult Clinic, Westside Women's Care Clinic, Pavilion C: Women's Care Clinic, La Casa-Quigg Newton Family Health Center, Lowry Family Health Center, Montbello Family Health Center, Westwood Family Health Center, Parkhill Family Health Center, Webb Center For Primary Care, Pena Southwest Clinic

What this trial measures

  • The change in parents & young adults' knowledge & intentions to obtain the HPV vaccineDay 0/Baseline

    Behavioral factors precede uptake of preventive vaccines. Measured by survey post watching HPV video.

  • Sociodemographic data (e.g., age, gender, ethnicity, insurance, income, zip code) as it relates to vaccine uptakeDay 0/Baseline

    Collected by the study team. Variables known as associated with vaccine uptake